Export financials
Spectrum Brands Holdings (SPB)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.

Spectrum Brands Holdings Financial Ratios 2025-2009 | SPB
Brief overview of Spectrum Brands Holdings's valuation multiples
Current figures are compared with the company's own five-year history for 2021–2025.
Key multiples at the end of the period are P/E 14.17x (median 21.56x), EV/EBITDA 12.39x (median 14.77x), P/S 0.5x (median 0.9x). The current ratio basket stands about 40.6% below the five-year comparison base. Earnings and risk trends should explain the discount.
The inverse P/E implies an earnings yield of 7.1%. This is not a dividend yield, but current earnings relative to market price.
Current measures of operating quality are ROE 5.2%, ROA 3%, ROCE 6.5%. Efficiency ratios are restrained, with capital and assets producing modest returns.
The time from paying for inputs to receiving cash rose from 45.6 days to 98.5 days. Cash turnover slowed.
Valuation takeaway
Spectrum Brands Holdings's discount may reflect genuine profitability issues rather than market inefficiency alone.
Annual Financial Ratios Spectrum Brands Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
14.2 | 21.6 | 1.5 | 27.8 | 22.7 | 34.7 | 5.4 | 3.1 | 29.7 | -14.9 | -4.7 | -205.7 | -33.1 | 13.3 | 20.5 | -35.0 | - |
P/S |
0.5 | 0.9 | 0.9 | 0.6 | 1.4 | 1.3 | 0.7 | 0.8 | 0.6 | 0.6 | 0.5 | 0.4 | 0.3 | 0.3 | 0.2 | 6.2 | - |
EPS |
3.9 | 4.1 | 45.6 | 1.8 | 4.4 | 2.2 | 9.8 | 20.8 | 3.3 | -6.2 | -2.8 | -0.5 | -0.7 | 0.1 | 0.1 | -0.1 | - |
EV (Enterprise Value) |
2.76 B | 4.02 B | 4.61 B | 6.26 B | 7.98 B | 6.56 B | 5.45 B | 8 B | 36.8 B | 36.5 B | 32.7 B | 29.3 B | 26.1 B | 23 B | 21.8 B | 7.89 B | -97.8 M |
EBITDA per Share |
8.67 | 8.99 | -2.9 | 3 | 5.01 | 2.76 | 9.65 | 11.9 | 22.3 | 23.5 | 18.2 | 31.8 | 46.7 | 31.1 | 11.1 | 1.38 | - |
EV/EBITDA |
12.4 | 14.8 | -40.3 | 51.1 | 37.1 | 8.6 | 8.7 | 14.8 | 12.1 | 10.5 | 13.6 | 7.2 | 4.3 | 2.7 | 10.3 | 43.3 | - |
PEG |
-0.12 | -0.17 | -0.03 | -1.45 | -1.87 | -1.54 | -0.1 | 0.01 | 0.19 | -0.23 | 0.01 | -8.61 | 0.16 | 0.02 | 0.19 | - | - |
P/B |
0.7 | 1.3 | 1.0 | 1.6 | 2.9 | 2.4 | 1.5 | 1.5 | 4.2 | 4.6 | 4.5 | 1.5 | 1.4 | 0.8 | 0.8 | 4.5 | - |
P/CF |
7.0 | 16.5 | -6.4 | -37.0 | 14.9 | 11.7 | -44.6 | 8.6 | 4.3 | 3.6 | 15.8 | 4.2 | 3.6 | 2.1 | 4.7 | 103.7 | - |
ROE % |
5.23 | 5.83 | 71.56 | 5.67 | 12.82 | 6.91 | 27.79 | 48.59 | 13.98 | -31.15 | -94.90 | -0.71 | -4.34 | 5.98 | 3.92 | -21.64 | - |
ROA % |
2.96 | 3.25 | 34.26 | 1.24 | 3.55 | 1.91 | 9.02 | 9.92 | 0.30 | -0.56 | -1.72 | -0.03 | -0.16 | 0.36 | 0.15 | -3.78 | - |
ROCE % |
6.54 | 7.97 | -8.17 | 1.84 | 6.57 | 0.61 | 7.54 | 4.83 | 1.49 | 1.89 | 1.44 | 2.25 | 2.95 | 2.18 | 1.03 | 9.22 | - |
Current Ratio |
2.3 | 2.3 | 1.9 | 1.3 | 1.4 | 1.4 | 1.5 | 2.5 | 1.2 | 3.0 | 17.6 | 18.2 | 16.8 | 27.9 | 2.5 | 1.4 | - |
DSO |
75.2 | 68.5 | 45.3 | 28.9 | 45.6 | 59.7 | 41.4 | 33.6 | 41.5 | 154.4 | 39.7 | 35.8 | 40.3 | 33.8 | 41.4 | - | - |
DIO |
93.3 | 91.0 | 113.8 | 114.5 | - | - | 80.2 | 92.2 | 90.4 | 86.6 | 90.9 | 78.7 | 84.3 | 77.3 | 77.1 | - | - |
DPO |
69.9 | 78.1 | 77.7 | 71.7 | - | - | 66.8 | 79.9 | 85.0 | 68.3 | 74.8 | 66.4 | 70.7 | 55.7 | 58.3 | - | - |
Operating Cycle |
168.4 | 159.5 | 159.1 | 143.3 | 45.6 | 59.7 | 121.6 | 125.9 | 131.9 | 241.1 | 130.6 | 114.5 | 124.6 | 111.1 | 118.5 | - | - |
Cash Conversion Cycle |
98.5 | 81.4 | 81.3 | 71.6 | 45.6 | 59.7 | 54.8 | 46.0 | 46.9 | 172.8 | 55.8 | 48.1 | 53.9 | 55.4 | 60.2 | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Financial Ratios Spectrum Brands Holdings
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-1.16 | 0.95 | 1.21 | 1.21 | 0.8 | 0.8 | 0.03 | 0.84 | 0.21 | 0.21 | 2.03 | 0.85 | 46.07 | 46.07 | -1.31 | -0.51 | 1.39 | 0.8 | 0.39 | 1.68 | 3.27 | 0.72 | 0.86 | - | 1.05 | 3.37 | -1.26 | -0.75 | -1.97 | -0.53 | -0.75 | -2.11 | -2.32 | 12.39 | -2.11 | 15.69 | -0.81 | 0.07 | 2.53 | 6.57 | -0.04 | -0.67 | 1.06 | -0.18 | -0.73 | -0.38 | -0.17 | -0.56 | -0.03 | 0.28 | -0.56 | -0.28 | -1.45 | 0.45 | -0.28 | 0.31 | 0.79 | -1.07 | 0.31 | 0.12 | -0.77 | 1.16 | -0.45 |
EBITDA per Share |
1.76 | 2.92 | 2.26 | 2.26 | 1.84 | 1.84 | 1.28 | 2.48 | 2.14 | 2.14 | 2.99 | 1.16 | -2.79 | -2.79 | -1.59 | -0.2 | 1.06 | 1.25 | 0.1 | 1.23 | 3.29 | 1 | 1.77 | - | 5.07 | 3.01 | 2.31 | -0.09 | 5.81 | 2.64 | -0.09 | 1.71 | 8.81 | 4.12 | 1.7 | 2.78 | 10.3 | 4.14 | 0.3 | 0.36 | 2.55 | 1.17 | 0.7 | 0.62 | 0.77 | -0.05 | 0.33 | -0.93 | 1.57 | 1.68 | -0.76 | 1.51 | 1.93 | 1.55 | 1.51 | 1.63 | 1.07 | 0.72 | 1.63 | - | -0.07 | 1.03 | - |
ROE % |
2.70 | 5.20 | 5.09 | 3.64 | 3.31 | 2.55 | 1.79 | 4.45 | 4.56 | 76.93 | 149.26 | 142.01 | 139.06 | 70.90 | 0.76 | 6.50 | 13.21 | 18.18 | 17.72 | 19.01 | 17.22 | 18.06 | 11.98 | 9.49 | 7.05 | -1.74 | -13.57 | -11.64 | -17.24 | -19.01 | 8.17 | 3.16 | 73.06 | 76.91 | 51.54 | 125.59 | 102.46 | 104.79 | 83.68 | 50.00 | 2.61 | -20.63 | -12.69 | -51.72 | -51.66 | -27.54 | -7.84 | -9.68 | -5.53 | 9.05 | 16.52 | 20.44 | 30.98 | 9.59 | -16.18 | -6.19 | 2.83 | 34.20 | 38.69 | 32.40 | 15.11 | 24.27 | -6.97 |
ROA % |
1.55 | 2.86 | 2.78 | 1.98 | 1.80 | 1.40 | 1.00 | 1.58 | 30.18 | 59.28 | 59.12 | 58.19 | 57.21 | 28.94 | 0.22 | 1.41 | 3.18 | 4.81 | 4.83 | 5.26 | 4.75 | 4.98 | 3.30 | 2.62 | 1.91 | -0.81 | -4.14 | -3.71 | -4.49 | -4.15 | 1.54 | 0.78 | 7.86 | 9.27 | 4.08 | 6.94 | 1.94 | 1.99 | 1.62 | 0.79 | 0.10 | -0.28 | -0.13 | -0.82 | -1.07 | -0.68 | -0.14 | -0.40 | -0.14 | 0.24 | 0.28 | 0.55 | 0.92 | 0.22 | -0.69 | -0.30 | -0.00 | 1.25 | 1.53 | 1.23 | 0.57 | 0.92 | -0.26 |
ROCE % |
6.00 | 6.80 | 6.16 | 5.77 | 6.54 | 7.18 | 7.81 | 10.14 | 9.02 | 1.86 | -5.30 | -15.17 | -17.89 | -12.48 | -4.66 | 1.24 | 4.67 | 11.01 | 10.04 | 13.73 | 20.21 | 20.07 | 22.89 | 19.82 | 16.68 | 17.69 | 16.43 | 8.92 | 13.86 | 16.56 | 17.84 | 22.12 | 26.57 | 45.87 | 52.40 | 54.34 | 55.62 | 92.97 | 109.16 | 124.10 | 142.09 | 82.77 | 40.59 | 28.17 | -14.20 | -13.48 | 15.11 | -3.60 | 43.03 | 61.32 | 70.63 | 108.06 | 95.99 | 77.86 | 59.58 | 53.13 | 30.52 | 33.75 | 29.37 | 11.08 | -4.91 | 13.46 | 2.53 |
Current Ratio |
2.1 | 2.2 | 2.2 | 2.2 | 2.1 | 2.1 | 2.1 | 2.3 | 2.2 | 2.2 | - | 1.9 | 1.7 | 1.7 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.4 | 1.4 | 1.4 | 1.4 | - | 1.4 | 1.4 | 1.4 | 1.4 | 1.5 | 1.5 | 1.5 | 1.2 | 1.3 | 1.3 | 1.3 | 1.2 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.0 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | - | 1.1 | 1.1 | 1.1 |
DSO |
69.1 | 69.3 | 69.7 | 75.6 | 78.8 | 77.5 | 81.0 | 80.4 | 72.5 | 36.2 | 34.0 | 59.7 | 46.0 | 42.0 | 37.8 | 34.9 | 10.6 | 36.6 | 52.3 | 51.1 | 14.8 | 44.6 | 14.9 | - | 31.2 | 46.5 | 75.8 | 68.9 | 32.8 | 31.8 | 38.8 | 37.9 | 29.7 | 29.0 | 32.1 | 26.9 | 53.7 | 49.0 | 49.6 | 83.0 | 68.5 | 55.9 | 69.2 | 94.4 | 45.1 | 48.0 | 52.8 | 51.3 | 35.3 | 33.4 | 41.9 | 38.0 | 37.2 | 39.5 | 38.1 | 36.6 | 31.6 | 37.4 | 17.1 | 15.4 | 20.2 | - | - |
DIO |
117.6 | 97.6 | 94.5 | 100.4 | 106.3 | 110.0 | 113.4 | 97.7 | 84.2 | 42.1 | 46.8 | 100.5 | - | 107.6 | - | 127.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
84.5 | 71.0 | 70.0 | 70.4 | 70.7 | 73.5 | 78.4 | 75.4 | 70.7 | 35.4 | 39.2 | 86.0 | - | 92.5 | - | 71.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | 176.0 | - | 187.6 | 194.4 | 178.1 | - | - | - | 160.2 | - | 149.6 | 37.8 | 162.4 | 10.6 | 36.6 | 52.3 | 51.1 | 14.8 | 44.6 | 14.9 | - | 31.2 | 46.5 | 75.8 | 68.9 | 32.8 | 31.8 | 38.8 | 37.9 | 29.7 | 29.0 | 32.1 | 26.9 | 53.7 | 49.0 | 49.6 | 83.0 | 68.5 | 55.9 | 69.2 | 94.4 | 45.1 | 48.0 | 52.8 | 51.3 | 35.3 | 33.4 | 41.9 | 38.0 | 37.2 | 39.5 | 38.1 | 36.6 | 31.6 | 37.4 | 17.1 | 15.4 | 20.2 | - | - |
Cash Conversion Cycle |
- | - | - | 105.6 | - | 114.1 | 116.1 | 102.7 | - | - | - | 74.2 | - | 57.1 | 37.8 | 91.0 | 10.6 | 36.6 | 52.3 | 51.1 | 14.8 | 44.6 | 14.9 | - | 31.2 | 46.5 | 75.8 | 68.9 | 32.8 | 31.8 | 38.8 | 37.9 | 29.7 | 29.0 | 32.1 | 26.9 | 53.7 | 49.0 | 49.6 | 83.0 | 68.5 | 55.9 | 69.2 | 94.4 | 45.1 | 48.0 | 52.8 | 51.3 | 35.3 | 33.4 | 41.9 | 38.0 | 37.2 | 39.5 | 38.1 | 36.6 | 31.6 | 37.4 | 17.1 | 15.4 | 20.2 | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Multiples are an important financial analysis tool for the company Spectrum Brands Holdings, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
Financial Ratios of other stocks in the Household products industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
|
Coty
COTY
|
$ 3.05 | -5.13 % | $ 2.68 B | ||
|
Dogness (International) Corporation
DOGZ
|
$ 0.77 | 5.11 % | $ 13.7 M | ||
|
e.l.f. Beauty
ELF
|
$ 113.78 | -0.84 % | $ 6.63 B | ||
|
Edgewell Personal Care Company
EPC
|
$ 26.98 | -4.39 % | $ 1.28 B | ||
|
Acme United Corporation
ACU
|
$ 63.2 | -0.6 % | $ 239 M | ||
|
Revlon
REV
|
- | -4.41 % | $ 212 M | ||
|
Mannatech, Incorporated
MTEX
|
$ 8.51 | 4.29 % | $ 16.2 M | ||
|
Colgate-Palmolive Company
CL
|
$ 93.4 | -1.21 % | $ 75.5 B | ||
|
Nature's Sunshine Products
NATR
|
$ 12.26 | -3.54 % | $ 221 M | ||
|
Nu Skin Enterprises
NUS
|
$ 4.76 | -4.51 % | $ 235 M | ||
|
Newell Brands
NWL
|
$ 5.56 | -2.11 % | $ 2.33 B | ||
|
Church & Dwight Co.
CHD
|
$ 105.0 | -0.91 % | $ 25.5 B | ||
|
The Procter & Gamble Company
PG
|
$ 156.84 | -1.61 % | $ 366 B | ||
|
The Estée Lauder Companies
EL
|
$ 103.66 | -2.32 % | $ 37.6 B | ||
|
United-Guardian
UG
|
$ 6.75 | -0.15 % | $ 31 M | ||
|
Unilever PLC
UL
|
$ 64.4 | -1.26 % | $ 141 B | ||
|
Hims & Hers Health
HIMS
|
$ 29.21 | -0.31 % | $ 6.57 B | ||
|
LifeVantage Corporation
LFVN
|
$ 5.95 | -0.34 % | $ 74.6 M | ||
|
Inter Parfums
IPAR
|
$ 113.2 | -2.33 % | $ 3.63 B | ||
|
Helen of Troy Limited
HELE
|
$ 28.38 | -3.54 % | $ 653 M | ||
|
The Clorox Company
CLX
|
$ 84.77 | -3.05 % | $ 10.5 B | ||
|
Kimberly-Clark Corporation
KMB
|
$ 106.64 | -1.56 % | $ 35.4 B | ||
|
Natura &Co Holding S.A.
NTCO
|
- | - | $ 9.02 B | - | |
|
USANA Health Sciences
USNA
|
$ 14.22 | -3.4 % | $ 264 M |